Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)

Phase 2 Completed 76 enrolled Fundación Renal Iñigo Alvarez De Toledo Infociencia S.L · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport.

Timeline

Start: 2006-09
Primary completion: 2008-11
Completion: 2009-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bemiparin	Other / unclassified	3500 iu	—

Indications

No indication recorded.